TabsDetailsBasic DetailsDate Posted: Tuesday, February 25, 2014Status: CompleteMedical Product: anti-diabetic agent (ADA)Health Outcome(s): kidney stoneDescription: Modular program-based one-time assessment of prevalence and incidence of kidney stones among all members and among those with a pre-existing condition of anti-diabetic agent (ADA) use. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2004 – December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 9, version 1.0; click here for more information. Queries were distributed in August 2013. This report includes data from 18 Data Partners.If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer. Read More Deliverables (1)Mini-Sentinel Modular Program Report: Kidney Stones and ADAsAdditional InformationAdditional DetailsFDA Center: CDERTime Period: 2004 - 2012Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Mini-Sentinel Distributed Database (MSDD)